ClinicalTrials.gg
CompletedNCT07624032Updated Jun 16, 2026

PNF Versus Cryotherapy in Delayed Onset Muscle Soreness

An interventional study of Proprioceptive Neuromuscular Facilitation and Local Cryotherapy in Delayed Onset Muscle Soreness (DOMS), sponsored by Universidad Pontificia de Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Universidad Pontificia de Salamanca · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jan 2025, registered May 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 341 studies in Pain with a site in Spain — 58 open to participants now, 67 under way, 7 of them phase 3. Pain · Spain.

Enrollment
251st of 295
29 · median 60
Started
2025
with 23 others
No phase
206 of 341
39 open now
Registered
332nd of 341
by date

Among the 341 studies in Pain with a site in Spain, this one is the 251st largest by enrollment of the 295 interventional ones that give a count, is one of 24 that started in 2025, is one of 206 with no phase, and was the 332nd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

58 of the 341 studies in Pain with a site in Spain are open now. Recruiting first, the newest first:

53 more — sign in →

All 58 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 341 studies in Pain with a site in Spain, or all of them as a file.
02

Study summary

This randomized, double-blind, single-center pilot clinical trial evaluated three interventions for delayed onset muscle soreness in the hamstring muscles.

Twenty-nine untrained adults were included. Delayed onset muscle soreness was induced using two eccentric hamstring exercises. Participants were then assigned to one of three groups: proprioceptive neuromuscular facilitation, local cryotherapy, or placebo consisting of water with sugar.

The main outcome was pressure pain threshold in the hamstring muscles. Other outcomes included knee range of motion, hamstring strength, pain intensity, perceived exertion, and blood lactate levels. Measurements were taken before the eccentric exercise, 24 hours after exercise before treatment, immediately after treatment, and 48 hours after exercise.

03

Conditions studied

  • Delayed Onset Muscle Soreness (DOMS)

Browse trials for

Keywords

  • Delayed onset muscle soreness
  • DOMS
  • Proprioceptive neuromuscular facilitation
  • PNF
  • Cryotherapy
  • Eccentric exercise
  • Hamstrings
  • Blood lactate
  • Physical therapy
  • Pressure pain threshold
  • Muscle strength
  • Range of motion
  • Pain intensity
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged between 18 and 45 years.
  • Participants who did not usually perform physical exercise or whose exercise was not focused on the lower limbs.
  • Participants who had previously experienced delayed onset muscle soreness and were familiar with its effects.

Exclusion criteria

Exclusion Criteria:

  • Musculoskeletal injury of the lower limb.
  • Pregnancy.
  • Diabetes.
  • Cardiovascular problems.
  • History of cancer.
  • diseases, including Raynaud disease or rheumatoid arthritis.
  • Sensory disorders.
  • Skin disorders.
  • Skin conditions.
  • Peripheral venous or lymphatic vascular insufficiency.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Proprioceptive Neuromuscular Facilitation

    Participants received a proprioceptive neuromuscular facilitation intervention targeting the hamstring muscles 24 hours after eccentric exercise-induced delayed onset muscle soreness.

    Other: Proprioceptive Neuromuscular Facilitation

  • Experimental
    Cryotherapy

    Participants received local cryotherapy over the hamstring muscles 24 hours after eccentric exercise-induced delayed onset muscle soreness.

    Other: Local Cryotherapy

  • Placebo comparator
    water with sugar

    Participants received a placebo intervention consisting of water with sugar 24 hours after eccentric exercise-induced delayed onset muscle soreness.

    Other: Placebo: Water With Sugar

Interventions

  • OtherProprioceptive Neuromuscular Facilitation

    A contract-relax-antagonist-contract proprioceptive neuromuscular facilitation technique was applied to the hamstring muscles. The protocol included isometric hamstring contraction, rest, quadriceps contraction, and passive movement into a deeper hamstring stretch. The protocol was repeated twice on each leg.

  • OtherLocal Cryotherapy

    Participants were placed in prone position and an ice pack was applied over the hamstring muscles for 20 minutes. A thin cloth was placed between the ice pack and the skin to avoid direct contact.

  • OtherPlacebo: Water With Sugar

    Participants consumed 200 mL of water with 5 g of dissolved sugar after the eccentric exercise protocol.

06

What researchers measure

Primary outcomes

  1. Change in Pressure Pain Threshold in the Hamstring Muscles

    Pressure pain threshold was assessed using a pressure algometer over three points of maximum pain in the hamstring muscles. Three measurements were taken and the mean value was calculated.

    Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise

Secondary outcomes

  1. Change in Active Knee Range of Motion

    Active knee flexion and extension range of motion were assessed using a manual goniometer.

    Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise

  2. Change in Hamstring Muscle Strength

    Maximum hamstring strength was assessed using a handheld dynamometer.

    Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise

  3. Change in Pain Intensity

    Pain intensity was assessed using the 11-point Numeric Pain Rating Scale. Scores range from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and therefore a worse outcome.

    Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise

  4. Change in Blood Lactate Concentration

    Blood lactate concentration was measured using a Lactate Edge device.

    Time frame: Before exercise, immediately after exercise, and 48 hours after exercise

  5. Perceived Exertion After Eccentric Exercise

    Perceived exertion was assessed using the Modified Borg Rating of Perceived Exertion Scale after completion of the eccentric exercise protocol. Scores range from 0 to 10, where 0 indicates no exertion and 10 indicates maximal exertion. Higher scores indicate greater perceived exertion and therefore a worse outcome.

    Time frame: Immediately after eccentric exercise

07

Study locations

1 site
  • Clínica Universitaria Salus Infirmorum, Universidad Pontificia de Salamanca
    Madrid, Madrid 28015, Spain
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data related to the outcomes reported in the study may be shared upon reasonable request to the principal investigator. Data will only be shared for academic and research purposes, after approval by the study team, and in accordance with applicable data protection regulations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Apr 2025, 3 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 3 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2026
First posted
Jun 3, 2026
StartActual
Jan 1, 2025
Primary completionActual
Apr 26, 2025
CompletionActual
Apr 30, 2025
Last update
Jun 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07624032
Lead sponsor
Universidad Pontificia de Salamanca
Responsible party
Sara Perpiñá (Principal investigator and Professor of Physiotherapy, Universidad Pontificia de Salamanca) — Principal investigator
First posted
Jun 3, 2026
Start date
Jan 1, 2025
Primary completion
Apr 26, 2025
Completion
Apr 30, 2025
Last update
Jun 16, 2026

Study contacts

Sara Perpiña Martínez, PhD
principal investigator · Universidad Pontificia de Salamanca

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion